Bak, N
Ebdrup, B H
Oranje, B
Fagerlund, B
Jensen, M H
Düring, S W
Nielsen, M Ø
Glenthøj, B Y
Hansen, L K
Article History
Received: 27 October 2016
Revised: 31 January 2017
Accepted: 19 February 2017
First Online: 11 April 2017
Competing interests
: BHE is supported by the University of Copenhagen/Mental Health Services, Capital Region of Denmark, and has received lecture fees from and/or is part of Advisory Boards of Bristol-Myers Squibb, Eli Lilly and Company, Janssen-Cilag, Otsuka Pharma Scandinavia and Takeda Pharmaceutical Company. BYG is the leader of a Lundbeck Foundation Center of Excellence for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), which is partially financed by an independent grant from the Lundbeck Foundation based on international review and partially financed by the Mental Health Services in the Capital Region of Denmark, the University of Copenhagen and other foundations. All grants are the property of the Mental Health Services in the Capital Region of Denmark and administrated by them. The remaining authors declare no conflict of interest.